Abstract
We investigated the incidence and sequelae of angiographically visible distal embolization (AVDE) after primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction patients treated with aspirin, heparin, clopidogrel, and glycoprotein-IIb/IIIa inhibitors.
As part of TAPAS, AVDE was a predefined secondary endpoint. We compared angiographic and clinical characteristics, and outcomes of patients with and without AVDE after PCI. AVDE was present on 6.3% of 883 post-procedural angiograms. Angiographically visible distal embolization was associated with significantly worse outcomes, as expressed by lower myocardial blush grade, impaired ST-segment resolution, and higher enzyme levels (all P
In patients with triple anti-platelet therapy, the incidence of AVDE after PCI is low, compared with previous reports. Nevertheless, AVDE is associated with impaired myocardial reperfusion and poor outcome. Thrombus composition and size are related to AVDE after PCI.
Original language | English |
---|---|
Pages (from-to) | 908-915 |
Number of pages | 8 |
Journal | European Heart Journal |
Volume | 30 |
Issue number | 8 |
DOIs | |
Publication status | Published - Apr-2009 |
Keywords
- ST-elevation myocardial infarction
- Reperfusion
- Angioplasty
- Distal embolization
- NO-REFLOW PHENOMENON
- THROMBUS-ASPIRATION
- PRIMARY ANGIOPLASTY
- FOLLOW-UP
- REPERFUSION
- ABCIXIMAB
- TRIAL
- FLOW
- METAANALYSIS
- PREDICTOR